Primary care prescribing relating to the cardiovascular system represents 13% of total spend and 29% of total prescription items. The number of prescription items has increased 28% in the past 10 years, with the number of prescription items for lipid regulating drugs increasing 53%.
Prescribing in this chapter is predominantly generic; 95% of scripts written are for unbranded therapies.
GPrX Data’s online system contains prescribing data from across the UK for all therapies relating to the cardiovascular system, from ACE inhibitors to Xanthines, including lipid regulating drugs (such as statins), beta blockers, nitrates and fibrates.
The RxIndex below shows the performance of the nitrates brands currently available on prescription.